CCDC12 gene methylation in peripheral blood as a potential biomarker for breast cancer detection

Jingjing Liu,Yunhui Qu,Yutong Zhao,Feifei Liang,Longtao Ji,Zhi Wang,Jinyu Li,Zishan Zang,Haixia Huang,Jie Zhang,Wanjian Gu,Liping Dai,Rongxi Yang
DOI: https://doi.org/10.1080/1354750x.2024.2358302
2024-06-08
Biomarkers
Abstract:Background Aberrant DNA methylation has been identified as biomarkers for breast cancer detection. Coiled-coil domain containing 12 gene ( CCDC12 ) implicated in tumorigenesis. This study aims to investigate the potential of blood-based CCDC12 methylation for breast cancer detection.
biotechnology & applied microbiology,toxicology
What problem does this paper attempt to address?